GeneDx Holdings (WGS) Non Operating Income (2020 - 2026)

GeneDx Holdings (WGS) has reported Non Operating Income for 7 consecutive years, with -$717000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Non Operating Income rose 53.17% year-over-year to -$717000.0; the TTM figure through Mar 2026 stood at -$1.7 million (up 74.1% YoY), while the FY2025 annual figure was -$2.5 million, up 91.37% from the prior year.
• Non Operating Income retreated to -$717000.0 in Q1 2026 per WGS's latest filing, from $1.5 million in the prior quarter.
• Across five years, Non Operating Income topped out at $27.8 million in Q2 2022 and bottomed at -$6.7 million in Q1 2024.
• Historically, Non Operating Income has averaged $3.6 million across 5 years, with a median of $509000.0 in 2023.
• Annual changes were most pronounced in 2022 — Non Operating Income jumped 4003.23% — and 2024, when it tumbled 762.82%.
• GeneDx Holdings' Non Operating Income stood at $16.2 million in 2022, then sank by 88.83% to $1.8 million in 2023, then sank by 287.3% to -$3.4 million in 2024, then surged by 144.99% to $1.5 million in 2025, then plunged by 146.99% to -$717000.0 in 2026.
• Business Quant data shows WGS's Non Operating Income at -$717000.0 in Q1 2026, $1.5 million in Q4 2025, and -$4.1 million in Q3 2025.